SI
ONCY

Sprott Inc’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Sprott Inc’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-230,000
Closed -$561K – 158
2013
Q3 		$561K Sell
230,000
-40,000
-15% -$111K 0.06% 90
2013
Q2 		$778K Buy
+270,000
New +$747K 0.11% 80

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $62.7B AUM 37.65% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
IGIM
I.G. Investment Management Winnipeg, Manitoba, Canada $19.5B AUM 15.95% 1-Year Est. Return

Sprott Inc's ONCY Position: Q4 2013 in Review

Sprott Inc sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2013, closing a stake of 230,000 shares — an estimated $561K sold.

Sprott Inc first reported a position in ONCY in Q2 2013 and held it in 2 quarters. The position peaked at $778K in Q2 2013. 37 funds tracked by Wall St. Rank hold ONCY as of Q4 2013.

  • Sprott Inc reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2013 after selling out during the quarter.
  • Sprott Inc sold 230,000 ONCOLYTICS BIOTECH INC shares in Q4 2013, an estimated $561K.
  • Sprott Inc first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 2 quarters.
  • Sprott Inc's ONCOLYTICS BIOTECH INC position peaked at $778K in Q2 2013.
  • 37 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2013.

Based on Sprott Inc's 13F filing for Q4 2013, filed 5 Feb 2014.